Obesity Interventions | United States | 2018 | Market Analysis
Growth in the US obesity intervention market will be significant over the forecast period due to fast-rising sleeve gastrectomy and intragastric balloon procedure volumes. Growth will also be sustained by the large obese population in the US, as well as by advancements in existing treatments and techniques and the emergence of novel technologies. However, market growth will be hindered to some extent by a decline in gastric banding procedure volume and stagnant ASPs.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the obesity interventions market in the US across a 10-year period.